Mannkind (MNKD) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Mannkind Corporation  (NASDAQ: MNKD)

Mannkind Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MNKD Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 88.95 % 70.91 % 65.43 % 46.08 %
Gross Margin (Q1 TTM) 84.1 % 71.7 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 73.98 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) -10.57 % 21.45 % 18.99 % 20.49 %
EBITDA Margin (Q1 TTM) -3 % 25.15 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. --24.44 % 47.09 % 31.38 % 23.41 %
Operating Margin (Q1 MRQ) -1.85 % 17.27 % 16.58 % 16.05 %
Operating Margin (Q1 TTM) 4.11 % 20.33 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. --17.14 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) -18.15 % 13.66 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) -7.92 % 16.7 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) -18.43 % 10.09 % 8.15 % 11.42 %
Net Margin (Q1 TTM) -6.63 % 13.13 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Other Significant Segment
  Explore Other Significant Segment Segment  -
Afrezza Other Significant Segment
  Explore Afrezza Other Significant Segment Segment  -
V-Go Other Significant Segment
  Explore V-Go Other Significant Segment Segment  -
Collaborations and services
  Explore Collaborations and services Segment  -
Collaborations and services Other Significant Segment
  Explore Collaborations and services Other Significant Segment Segment  -
Royalties
  Explore Royalties Segment  -
Royalties Other Significant Segment
  Explore Royalties Other Significant Segment Segment  -
Product Revenue
  Explore Product Revenue Segment  -
Services
  Explore Services Segment  -
United Therapeutics Corporation
  Explore United Therapeutics Corporation Segment  -
United Therapeutics Corporation Commercial Supply
  Explore United Therapeutics Corporation Commercial Supply Segment  -
United Therapeutics Corporation Royalties Arrangement
  Explore United Therapeutics Corporation Royalties Arrangement Segment  -
Collaborations and services Co-Promotion Agreement Amphastar
  Explore Collaborations and services Co-Promotion Agreement Amphastar Segment  -
Collaborations and services United Therapeutics Corporation Commercial Supply Agreement
  Explore Collaborations and services United Therapeutics Corporation Commercial Supply Agreement Segment  -
License And Service
  Explore License And Service Segment  -
United Therapeutics Corporation Commercial Supply Agreement License And Service
  Explore United Therapeutics Corporation Commercial Supply Agreement License And Service Segment  -
Cipla Ltd
  Explore Cipla Ltd Segment  -
Furoscix Other Significant Segment
  Explore Furoscix Other Significant Segment Segment  -
United Therapeutics Corporation License Agreement
  Explore United Therapeutics Corporation License Agreement Segment  -
Collaborations and services United Therapeutics Corporation License Agreement
  Explore Collaborations and services United Therapeutics Corporation License Agreement Segment  -
United Therapeutics Corporation License Agreement License And Service
  Explore United Therapeutics Corporation License Agreement License And Service Segment  -
United Therapeutics Corporation Contract Asset
  Explore United Therapeutics Corporation Contract Asset Segment  -
Sale of product
  Explore Sale of product Segment  -
UT CSA
  Explore UT CSA Segment  -
UT CSA Sale of product
  Explore UT CSA Sale of product Segment  -
Other agreements UT CSA
  Explore Other agreements UT CSA Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) -8.03 % -0.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q1 TTM) 3.65 % 17.24 % 13.85 % 9.11 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) -24.45 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) 1.53 % -0.66 % 0.13 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q1 MRQ) -1.55 % 25.98 % 25.39 % 18.83 %
Effective Tax Rate (Q1 TTM) 16.31 % 21.21 % 22.93 % 19.44 %
Effective Tax Rate 5 Yr. Avg. - 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.